Literature DB >> 7016927

Resistance to trimethoprim in 1978-79 compared with 1973-75.

J M Hamilton-Miller, A Gooding, W Brumfitt.   

Abstract

The incidence of resistance to trimethoprim among urinary isolates between October 1978 and November 1979 was 11.5%, more than double the figure found April 1973 and October 1975. Of the resistant strains, 60% had a minimum inhibitory concentration in excess of 1 mg/ml. Escherichia coli and Proteus mirabilis showed the greatest increase in resistance since the previous study. Rather wide fluctuations occurred in the incidence of resistance for various species when the figures were analysed over two-month periods, hence studies of short duration must be interpreted with caution. There are not yet enough data from this or other studies for the cause of the increased incidence of resistance to trimethoprim to be determined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016927      PMCID: PMC493310          DOI: 10.1136/jcp.34.4.439

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections.

Authors:  A Kasanen; M Anttila; R Elfving; P Kahela; H Saarimaa; H Sundquist; R Tikkanen; P Toivanen
Journal:  Ann Clin Res       Date:  1978

2.  Susceptibility of urinary pathogens to various antimicrobial substances: a four-year study.

Authors:  R N Grüneberg
Journal:  J Clin Pathol       Date:  1976-04       Impact factor: 3.411

3.  Compatibility groups of R-factors for trimethoprim resistance isolated in Italy.

Authors:  E Romero; M Perduca
Journal:  J Antimicrob Chemother       Date:  1977-11       Impact factor: 5.790

4.  Trimethoprim R factors in enterobacteria from clinical specimens.

Authors:  R S Jobanputra; N Datta
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

5.  Bacteriological, pharmacological and clinical studies with trimethoprim-sulphonamide combinations with particular reference to the treatment of urinary infections.

Authors:  W Brumfitt; M C Faiers; R E Pursell; D S Reeves; A R Turnbull
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

6.  Resistance to trimethoprim.

Authors:  W Brumfitt; J M Hamilton-Miller; A Gooding
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

7.  R-factor mediated trimethoprim resistance: result of two three-month clinical surveys.

Authors:  S G Amyes; A M Emmerson; J T Smith
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

8.  Trimethoprim--resistant coliforms.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

9.  [Trimethoprim resistance plasmids: transferability and incompatibility groups (author's transl)].

Authors:  J F Acar; F W Goldstein; G R Gerbaud; Y A Chabbert
Journal:  Ann Microbiol (Paris)       Date:  1977-01

10.  Trimethoprim-resistant bacteria: cross-resistance patterns.

Authors:  D Grey; J M Hamilton-Miller
Journal:  Microbios       Date:  1977
View more
  11 in total

Review 1.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

2.  Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.

Authors:  F R Sattler; J S Remington
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

3.  Trimethoprim resistance in Gram negative urinary pathogens.

Authors:  R Maskell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

4.  Resistance of urine pathogens to trimethoprim in Finland.

Authors:  S Räisänen; N Keränen; H Syrjälä
Journal:  J Clin Pathol       Date:  1982-01       Impact factor: 3.411

5.  Co-trimoxazole or trimethoprim alone? A viewpoint on their relative place in therapy.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 6.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 7.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

8.  Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections.

Authors:  W Brumfitt; J M Hamilton-Miller; H Ludlam; V Damjanovic; R Gargan
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

9.  Pivmecillinam in complicated urinary infections failing to respond to conventional therapy.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1982       Impact factor: 3.553

10.  Trimethoprim resistance in hospitals.

Authors:  P Huovinen; R Mäntyjärvi; P Toivanen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.